Scientific Industries ( (SCND) ) has released its Q3 earnings. Here is a breakdown of the information Scientific Industries presented to its

Gross profit was $1.4 million, an increase of 15.4%, and $3.7 million, a decrease of 4.4%, respectively, for the three- and nine-month periods ended September 30, 2024, compared to $1.2 million, and $3.9 million, respectively, in the prior year periods.

Net Revenue of $19.9 Million Through the 9 Months ended September 30, 2024 Represents a 61% Increase over FY 2023 Net Revenue of $12.3 Million . New Pro-U.S. Border Security

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),